In silico study of the activities of isolated compounds of Bauhinia variegata Linn
DOI:
https://doi.org/10.33448/rsd-v9i12.11352Keywords:
Bauhinia variegata Linn; Prediction; Pharmacology.Abstract
Bauhinia variegata Linn belongs to the Fabaceae family and is popularly used as a hypoglycemic agent. Phytochemical studies isolated flavonoids, terpenes, steroids and naphthalene derivatives, and for this reason, this article aims to describe the results of pharmacokinetics, toxicity and biological activities obtained in in silico studies of the isolated molecules for B. variegata. The online databases for data collection were: PreADMET and PASS online. For the design of chemical structures and physico-chemical characterization: MarvinSketch, Mcule property calculator and Chemicalize. The results suggested that Caempferol, 2'-hydroxy-4',6'-dimethoxy-3,4-methylenedioxyhalhal, Campferol3-O-α-L-ramnoside, (2S)-5,7-dimethoxy-3',4'-methylenedioxyflavanone and 5,6-dihydro-1,7-dihydroxy-3,4-dimethoxy-2-methyldibenz [b, f] oxepine showed a better pharmacokinetic pattern, due to the physical characteristics -chemicals are aligned with Lipinsk, however, all compounds showed inhibition on cytochrome P450 (CYP). Lupeol was the most favorable as an antineoplastic agent; β-Sitosterol and Heptatricontan-12, 13-diol antiviral capacity; flavonoids (Campferol3-O-α-L-ramnoside and 2'-hydroxy-4',6'-dimethoxy-3,4-methylenedioxyhalhal) and Lupeol antiparasitic activity; Campferol3-O-α-L-ramnoside and Lupeol potential anti-inflammatory. The hypoglycemic action has not been found, but the hormone release pathway could be different. The compounds obtained toxic results at different trophic levels and in relation to the evaluation of carcinogenicity and mutagenicity. Based on these aspects, Campferol3-O-α-L-ramnoside and Lupeol appear to be the most promising molecules in biological activities, being able to act as antimalarials, with necessary modifications in their structure to reduce their toxic effects, as well as presenting acceptable pharmacokinetic aspects if they are candidates for drugs.
References
Ajay, A., Bermis, G. W., & Murkco, M. A. (1999). Designing libraries with CNS activity. J Med Chem., 42 (24), 4942-4951. doi:10.1021/jm990017w.
Alves, C. Q., Brandão, H. N., David, J. M., David, J. P., & Lima, L. da. S. (2007). Avaliação da atividade antioxidante de flavonóides. Diálogos & Ciência, 12, 1-8.
Ames, B. N., Mccann, J., & Yamasaki, E. (1975). Methods for detecting carcinogens and mutagens with the Salmonella/Mammalian-microsome mutagenicity test. Mutat. Res., 31 (6), 347-364. doi:10.1016/0165-1161(75)90046-1.
Audi, E. A. & Pussi, F. D. (2008). Isoenzimas do CYP450 e biotransformação de drogas. Acta Scientiarum. Biological Sciences, 22 (2), 599-604. doi: 10.4025/actascibiolsci.v22i0.2810.
Azevedo, C. R., Maciel, F. M, Silva, L.B., Ferreira, A. T. S., Da Cunha, M., Machado, O. L. T., Fernandes, K. V. S., Oliveira, A. E. A., & Xavier-Filho, J. (2006). Isolation and intracellular localization of insulin-like proteins from leaves of Bauhinia variegata. Braz. J. Med. Biol. Res., 39 (11), 1435-1444. doi: 10.1590/S0100-879X2006001100007.
Brandão, D. L. N, Martins, H. P. S., Tomaz, J. M. O., Ferreira, G. G., Ramos, H. O., Percário, S., & Dolabela, M. F. (2020). Estudo in silico de diterpenos isolados de Portulaca pilosa L e sua correlação com estudos etnobotânicos. Research, Society and Development, 9 (11), e99491110635. doi: 10.33448/rsd-v9i11.10635.
Bushra, Khan, D. F., Ullah, H., & Khan, S. (2018). Isolation and characterization of two new compounds from the plant Bauhinia variegata. Indo Am. J. Pharm., 5 (2), 862-867. doi: 10.5281/zenodo.1175241.
Chemicalize. (2020). Calculate properties instantly, search chemical data, and draw molecules online. Recuperado de https://chemicalize.com/.june.
Correa-Barbosa, J., Silva, M. C. M. da, Percário, S., Brasil, D. do S. B., Dolabela, M. F., & Vale, V. V. (2020). Aspidosperma excelsum and its pharmacological potential: in silico studies of pharmacokinetic prediction, toxicological and biological activity. Research, Society and Development, 9 (10), e3629108635. doi: 10.33448/rsd-v9i10.8635.
Costa, C. R., Olivi, P., Botta, C. M. R., & Espindola, E. L. G. (2008). A toxicidade em ambientes aquáticos: discussão e métodos de avaliação. Quim. Nova, 3 (7), 1820-1830. doi: 10.1590/S0100-40422008000700038.
Das, A., Jawed, J. J., Das, M. C., Sandhu, P., De, U. C., Dinda, B., Akhter, Y., & Bhttacharjee, S. (2017). Antileishmanial and immunomodulatory activities of lupeol, a triterpene compound isolated from Sterculia villosa. International journal of antimicrobial agentes, 50 (4), 512-522. doi: 10.1016/j.ijantimicag.2017.04.022.
De los Ríos, C., Gil. H., & Hidalgo, D. (2003). Efecto inhibitorio de Bauhinia variegata L. sobre la glucación no enzimática de la hemoglobina. Rev. Facul. Farm., 45 (3), 12-16. Recuperado de http://bdigital.ula.ve/storage/pdf/farma/v45n2/art3.pdf.
Dos Santos, R. da. C., Daniel, I. C., Próspero, D. F. A., & Costa, C. L. S. da. (2018). Modificação molecular incremental: análise de parâmetros físico-químicos, farmacocinéticos e toxicológicos in silico de fármacos inibidores seletivos da recaptação de serotonina (ISRSs). Boletim Informativo Geum, 9 (2), 31-38.
Dukes, J. D., Whitley, P., & Chalmers, A. D. (2011). The MDCK variety pack: choosing the right strain. BMC cell biology, 12 (43), 1-4. doi: 10.1186/1471-2121-12-43.
Filimonov, D. A., Lagunin, A. A., Gloriozova, T. A., Rudik, A. V., Druzhilovskii, D. S., Pogodin, P. V., & Poroikov, V. V. (2014). Prediction of the biological activity spectra of organic compounds using the PASS online web resource. Chemistry of Heterocyclic Compounds, 50 (3), 444-457. doi: 10.1007/s10593-014-1496-1.
Gomes, B. F. & Accardo, C. de. M. (2019). Mediadores imunoinflamatórios na patogênese do diabetes mellitus. Einstein (São Paulo), 17 (1), 1-5. doi: 10.31744/einstein_journal/2019RB4596.
Gonçalves, J. E. (2010). Padronização das condições para cultura de células Caco-2 visando à obtenção de membranas viáveis ao estudo da permeabilidade in vitro da rifampicina. Tese (Doutorado), São Paulo: FCF-USP. Recuperado de https://teses.usp.br/teses/disponiveis/9/9139/tde-31012011-162346/pt-br.php.
Guilhermino, L., Diamantino, T., Silva, M. C., & Soares, A. M. V. M. (2000). Acute toxicity test with Daphnia magna: Na alternative to mammals in the Prescreening of Chemical Toxicity? Ecotoxicol Environ Saf., 46 (3), 57-362. doi:10.1006/eesa.2000.1916.
Irvine, J. D., Takahashi, L., Lockhart, K., Cheong, J., Tolan, J. W., Selick, H. E., & Grove, R. (1999). MDCK (Madin–Darby canine kidney) cells: a tool for membrane permeability screening. Journal of pharmaceutical sciences, 88 (1), 28-33. doi: 10.1021/js9803205.
Jash, S. K., Roy, R., & Gorai, D. (2014). Bioactive constituents from Bauhinia variegata Linn. Internacional Journal of Pharmaceutical and Biomedical Research, 5 (2), 51-54.
Kruidering, M. & Evan, G. I. (2000). Caspase‐8 in apoptosis: the beginning of “the end”? IUBMB life, 50 (2), 85-90. doi: 10.1080/713803693.
Lipinski, C. A. (2004). Lead- and drug-like compounds: the rule of five revolution. Drug Discovery today: Technologies, 1 (4), 337-341. doi:10.1016/j.ddtec.2004.11.007.
Lusa, M. G. & Bona, C. (2009). Análise morfoanatômica comparativa da folha de Bauhinia forficata Link e B. variegata Linn. (Leguminosae, Caesalpinioideae). Acta Bot. Bras., 23 (1), 196-211. doi: 10.1590/S0102-33062009000100022.
Maheswara, M., Rao, Y. K., Siddaiah V., & Rao, C. V. (2006). Isolation of New Chalcone from the Leaves of Bauhinia variegata. Asian Journal of Chemistry, 18 (1), 419-422.
Mcule. (2020). Property calculator. Recuperado de https://mcule.com/apps/property-calculator/.
Mendes, C. C., Marinho, C. M. F., Moreira-Junior, V. F., Queiroz, F. M., Dantas, G. L. S., Macedo, M. F. S., Oliveira, C. N., & Schwarz, A. (2010). Evaluation of Bauhinia monandra aqueous and ethanol extracts in pregnant rats. Pharmaceutical biology, 48 (7), 780-785. doi: 10.3109/13880200903280018.
Mishra, A., Sharma, A. K., Kumar, S., Saxena, A. K., & Pandey, A. K. (2013). Bauhinia variegata leaf extracts exhibit considerable antibacterial, antioxidant, and anticancer activities. BioMed Research International, 2013, 1-10. doi: 10.1155/2013/915436.
Moda, T. L. (2007). Desenvolvimento de modelos in silico de propriedades de ADME para a triagem de novos candidatos a fármacos. Dissertação (Mestrado). São Carlos: IFSC-USP. Recuperado de https://www.teses.usp.br/teses/disponiveis/76/76132/tde-22032007-112055/publico/Dissertacao_Tiago_Moda.pdf.
Nogueira, A. C. O. & Sabino, C. V. S. (2012). Revisão do Gênero Bauhinia Abordando Aspectos Científicos das Espécies Bauhinia forticata Link e Bauhinia variegata L. de Interesse para a Indústria Farmacêutica. Rev Fitos, 7 (2), 77-84.
Pandey, S. (2017). In vivo antitumor potential of extracts from different parts of Bauhinia variegata linn. Against b16f10 melanoma tumour model in c57bl/6 mice. Appl. Cancer Res., 37 (1), 1-14, 2017. doi: 10.1186/s41241-017-0039-3.
PASS Online. Prediction of biological activity. Recuperado de http://www.way2drug.com/PASSonline/.
Pereira, A. S., Shitsuka, D. M., Pereira, F. J., & Shitsuka, R. (2018). Metodologia da pesquisa científica. Santa Maria: UFSM, NTE. Recuperado de https://repositorio.ufsm.br/bitstream/handle/1/15824/Lic_Computacao_Metodologia-Pesquisa-Cientifica.pdf.
Preadmet. (2020). ADME TOX calculation. Recuperado de http://preadmet.bmdrc.kr.
Rajani, G. P. & Ashok, P. (2009). In vitro antioxidant and antihyperlipidemic activities of Bauhinia variegata Linn. Indian J. Pharmacol., 41 (5), 227-232. doi: 10.4103/0253-7613.58513.
Rajkapoor, B., Jayakar, B., & Murugesh, N. (2003). Antitumour Activity of Bauhinia variegata Against Ehrlich Ascites Carcinoma Induced Mice. Pharm. Biol., 41 (8), 604-607. doi: 10.1080/13880200390501947.
Rang, H. P., Ritter, J. M., Flower, R. J., & Henderson, G. (2016). Rang & Dale: Farmacologia (8a ed.). Rio de Janeiro: Elsevier.
Rao, Y. K., Fang, S. H., & Tzeng, Y. M. (2008). Antiinflammatory activities of flavonoids and a triterpene caffeate isolated from Bauhinia variegata. Phytother. res., 22 (7), 957-962. doi: 10.1002/ptr.2448.
Reddy, M. V. B., Reddy, M. K., Gunasekar, D., Caux, C., & Bodo, B. (2003). A flavanone and a dihydrodibenzoxepin from Bauhinia variegata. Phytochemistry, 64 (4), 879-882. doi: 10.1016/s0031-9422(03)00416-3.
Riesenman, C. (1995). Antidepressant drug interactions and the cytochrome P450 system: a critical appraisal. Pharmacotherapy: The J. of Human Pharmacology and Drug Therapy, 15 (6), 84S-99S. doi: 10.1002/j.1875-9114.1995.tb02909.x.
Saeidnia, S., Manayi, A., Gohari, A. R., & Abdollahi, M. (2014). The story of beta-sitosterol-a review. European. J. Med. Plants, 4 (5), 590-609. doi: 10.9734/EJMP/2014/7764.
Santos, V. L. dos. A, Gonsalves, A. de. A., & Araújo, C. R. M. (2018). Abordagem didática para o desenvolvimento de moléculas bioativas: regra dos cinco de Lipinski e preparação de heterociclo 1,3,4-oxadiazol em forno de micro-ondas doméstico. Quim. Nova, 41 (1), 110-115. doi: 10.21577/0100-4042.20170135.
Silva, F. C. (2015). Desenvolvimento de modelos de QSAR para identificação de substratos e inibidores de CYP3A4. Dissertação (Mestrado). Goiânia: PPGCF-UFG. Recuperado de http://repositorio.bc.ufg.br/tede/handle/tede/5266.
Silva, K. L. & Filho, V. C. (2002). Plantas do gênero Bauhinia: composição química e potencial farmacológico. Quim. Nova, 25 (3), 449-454. doi: 10.1590/S0100-40422002000300018.
Sisenando, H. A. A. A. C. N. (2009). Avaliação do potencial de mutagenicidade e toxidade da lectina hipoglicemiante de folha de Bauhinia monandra (pata-de-vaca). Dissertação (Mestrado). Natal: PPGCS-UFRN. Recuperado de https://repositorio.ufrn.br/handle/123456789/13226.
Souza, A. F. de. (2001). Clonagem, expressão e caracterização de um inibidor de tripsina isolado de sementes de Bauhinia variegata. Tese (Doutorado), São Paulo: UNIFESP. Recuperado de http://repositorio.unifesp.br/handle/11600/17692.
Vaz, A. M. S. F. & Tozzi, A. M. G. A. (2005). Sinopse de Bauhinia sect. Pauletia (Cav.) DC. (Leguminosae: Caesalpinioideae: Cercideae) no Brasil. Rev. Bras. Bot., 28 (3), 477-491. doi: 10.1590/S0100-84042005000300006.
Vijay, K. M. M. J., Eswarappa, B., Yadav, D. B., Jayadevaiah K. V., & Basavaraja, H. S. (2014). Isolation of Phytoconstituents from the Stem Bark of Bauhinia variegata Linn. PharmaTutor, 2 (9), 150-156.
Yang, Y., Bai, L., Li, X., Xiong, J., Xu, P., Guo, C., & Xue, M. (2014). Transport of active flavonoids, based on cytotoxicity and lipophilicity: an evaluation using the blood-brain barrier cell and Caco-2 cell models. Toxicol. in Vitro, 28 (3), 388-396. doi: 10.1016/j.tiv.2013.12.002.
Yazdanian, M., Glynn, S. L., Wright, J. L., & Hawi, A. (1998). Correlating partitioning and Caco-2 cell permeability of structurally diverse small molecular weight compounds. Pharm Res., 15 (9), 1490-1494. doi: 10.1023/A:1011930411574.
Yee S. (1997). In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man – fact or myth. Pharm Res., 14 (6), 763-766. doi: 10.1023/a:1012102522787.
Zhai, L., Chen, M., Blom, J., Theander, T.G., Christensen, S.B., & Kharazmi, A. (1999). The antileishmanial activity of novel oxygenated chalcones and their mechanism of action. J. Antimicrob. Chemother., 43 (6), 793-803. doi: 10.1093/jac/43.6.793.
Zucker, E. (1985). Hazard Evaluation Division Standard Evaluation Procedure: Acute toxicity test for freshwater Fish. Washington, USA: USEPA. Recuperado de https://ntrl.ntis.gov/NTRL/dashboard/searchResults/titleDetail/PB86129277.xhtml.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Lucas dos Santos Nunes; Jayanne Lilian Carvalo Gomes; Hanna Patrícia dos Santos Martins; Maria Fâni Dolabela
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
